Director, Market Access: Precision Medicine & Solid Tumor

Johnson & Johnson Innovative Medicine; Hopewell Township (OH); On-site; USD 164,000 - 283,000; Full time

Benefits offered by this job

Long-term incentive program

401(k) / Pension plan

Paid time off

Job summary

Johnson & Johnson Innovative Medicine is seeking a Director, Market Access Marketing, Precision Medicine & Solid Tumor Pipeline.

This role partners with PS&E and brand teams to shape access, evidence, reimbursement, testing, and customer requirements for precision medicine assets, while leading launch readiness for late-stage Solid Tumor Prostate assets and coordinating across NPBD, Global Market Access, and inline VAP teams.

Qualifications

• Bachelor’s degree required; advanced degree preferred.
• 10+ years in biopharma/diagnostics/healthcare with Market Access.
• Strong knowledge of US payer, provider, reimbursement and healthcare delivery dynamics.
• Experience leading across matrixed organizations; oncology focus preferred.

Responsibilities

• Lead Market Access strategy and launch readiness for late-stage Solid Tumor Prostate assets.
• Partner with NPBD, Global Market Access, Medical Affairs and Brand teams to shape access requirements.
• Embed Precision Medicine insights across market access teams and develop patient access resources.
• Translate payer/provider dynamics into actionable market access plans and tactics.
• Manage budgets and key agency partnerships to ensure high-quality execution.

Skills

Agility

Commercial Awareness

Leadership

Pricing Strategies

Program Management

Regulatory Compliance

Strategic Change

Health Economics

Global Market

Market Knowledge

Education

Bachelor’s degree

Job description

Johnson & Johnson Innovative Medicine is seeking a Director, Market Access Marketing, Precision Medicine & Solid Tumor Pipeline.

This role partners with PS&E and brand teams to shape access, evidence, reimbursement, testing, and customer requirements for precision medicine assets, while leading launch readiness for late-stage Solid Tumor Prostate assets and coordinating across NPBD, Global Market Access, and inline VAP teams.